Bal Pharma Ltd (BALPHARMA) — Announcement | 10 September 2026
Bal Pharma clarified that recent price volatility in its shares is market-driven with no price-sensitive information or material events identified, confirming compliance with SEBI disclosure norms and no pending reporting requirements.
About Bal Pharma Ltd (BALPHARMA)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when BALPHARMA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track BALPHARMA — Free💡 Ask AI about this filing
📊 More BALPHARMA filings
- Announcement — 25 September 2026Bal Pharma Ltd announced the closure of its trading window effective October 1, 2026, until 48 hours...
- 🟡 Board Meeting — 25 September 2026Bal Pharma announced at its September 24, 2026 AGM the re-appointment of Ravindra Kumar Kothari as D...
- 🟡 Board Meeting — 24 September 2026Bal Pharma held its 39th AGM on September 24, 2026, approving a Rs. 1.20 per share dividend for FY20...
- 🔴 Corporate Action — 7 September 2026Bal Pharma announced the allotment of 10 lakh convertible warrants to promoter Shailesh Siroya at ₹8...
- 🔴 Corporate Action — 27 August 2026Bal Pharma announced a final dividend of Rs 1.20 per share for FY 2025-26, payable after September 2...
🔥 Also filed on 10 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when BALPHARMA files new disclosures
Track BALPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track BALPHARMA — FreeFree account · 2 AI queries/day